Title |
Echocardiographic evaluation of cardiac function after cancer chemotherapy
|
---|---|
Published in |
Journal of Echocardiography, July 2017
|
DOI | 10.1007/s12574-017-0344-6 |
Pubmed ID | |
Authors |
Tomoko Negishi, Kazuaki Negishi |
Abstract |
Progress in cancer therapy has led to improved prognosis of patients with cancer and thus to a continuous rise of cancer survivors. However, it has simultaneously increased cardiovascular morbidity and mortality rates due to direct and/or indirect side effects of anticancer treatment. Similar to the rapid rise of patients with adult congenital disease, the number of patients suffering or at risk of cardiotoxicity has been steeply increasing and getting an emerging issue. Among the many facets of chemotherapy-induced cardiovascular toxicity, this review attempts to summarize echocardiographic evaluation of cardiac function after cancer chemotherapy by reviewing the definition, risk factors, brief history, limitation of left ventricular ejection fraction and myocardial strain imaging, as well as the limitations of this technique. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 40 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 20% |
Student > Bachelor | 5 | 13% |
Other | 4 | 10% |
Student > Master | 4 | 10% |
Lecturer > Senior Lecturer | 3 | 8% |
Other | 3 | 8% |
Unknown | 13 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 43% |
Nursing and Health Professions | 2 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Unknown | 20 | 50% |